Volume 85, Issue 1, Pages (January 2014)

Slides:



Advertisements
Similar presentations
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Advertisements

Volume 77, Issue 12, Pages (June 2010)
Volume 69, Issue 11, Pages (June 2006)
Independent and Joint Associations of Nutritional Status Indicators With Mortality Risk Among Chronic Hemodialysis Patients in the Dialysis Outcomes and.
Marlies Noordzij, Kitty J. Jager  Kidney International 
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease  Kevin E. Chan, Ravi I. Thadhani,
End-stage renal disease in developing countries
Volume 83, Issue 3, Pages (March 2013)
Volume 87, Issue 5, Pages (May 2015)
Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study.
Volume 63, Issue 1, Pages (January 2003)
Volume 84, Issue 3, Pages (September 2013)
Missed Hemodialysis Treatments: International Variation, Predictors, and Outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS)  Issa Al.
Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States  Austin G. Stack, Bhamidipati V.R.
The risk of hospitalization and modality failure with home dialysis
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population  Mark J. Sarnak, Bertrand L. Jaber  Kidney International 
International Differences in the Location and Use of Arteriovenous Accesses Created for Hemodialysis: Results From the Dialysis Outcomes and Practice.
Volume 87, Issue 1, Pages (January 2015)
Volume 85, Issue 1, Pages (January 2014)
Volume 94, Issue 3, Pages (September 2018)
Vitality Measured as Self-reported Energy Level and Clinical Outcomes in Hemodialysis Patients: The Japanese Dialysis Outcomes and Practice Pattern Study.
End-stage renal disease in living kidney donors
Volume 68, Issue 6, Pages (December 2005)
C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go 
Volume 80, Issue 9, Pages (November 2011)
Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns.
Volume 81, Issue 11, Pages (June 2012)
Comorbidity and confounding in end-stage renal disease
Iain C. Macdougall, MD  American Journal of Kidney Diseases 
Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought  Nicolas Rognant, Maurice Laville  Kidney.
David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD 
Survival advantage in Asian American end-stage renal disease patients1
Volume 77, Issue 7, Pages (April 2010)
Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia  Blair S. Grace, Philip A. Clayton, Alan.
Volume 82, Issue 5, Pages (September 2012)
Stephen P. McDonald  Kidney International Supplements 
Volume 92, Issue 2, Pages (August 2017)
Interdialytic Weight Gain: Trends, Predictors, and Associated Outcomes in the International Dialysis Outcomes and Practice Patterns Study (DOPPS)  Michelle.
Volume 70, Issue 12, Pages (December 2006)
Volume 67, Issue 3, Pages (March 2005)
Volume 65, Issue 6, Pages (June 2004)
The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral and Bone Disorder.
Volume 70, Issue 10, Pages (November 2006)
Volume 83, Issue 2, Pages (February 2013)
Alternate-day dialysis may be needed for hemodialysis patients
Volume 80, Issue 6, Pages (September 2011)
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Volume 68, Issue 1, Pages (July 2005)
Prehypertension: is it relevant for nephrologists?
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Volume 82, Issue 3, Pages (August 2012)
Volume 74, Issue 8, Pages (October 2008)
Volume 95, Issue 4, Pages (April 2019)
Volume 61, Issue 1, Pages (January 2002)
The Iranian model of living renal transplantation
Robert G. Nelson, Hal Morgenstern, Peter H. Bennett 
American Journal of Kidney Diseases
Volume 53, Issue 5, Pages (May 1998)
Renal replacement therapy in Latin America
Douglas E. Schaubel, Howard I. Morrison, Stanley S.A. Fenton 
Collecting and using patient and treatment center data to improve care: Adequacy of hemodialysis and end-stage renal disease surveillance1  William M.
Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes  Steven M. Brunelli, Ravi Thadhani,
Volume 77, Issue 12, Pages (June 2010)
Hemodialysis access failure: a call to action—revisited
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Associations of dialysis session length with mortality and hospitalizations. Associations of dialysis session length with mortality and hospitalizations.
Survival among hemodialysis patients by geographic region in DOPPS 3 (2005–2008), with and without adjustments for patient mix differences. Survival among.
Mortality risk by age at study entry across DOPPS regions.
Distribution of facility mean treatment time, by DOPPS region and phase. Distribution of facility mean treatment time, by DOPPS region and phase. Restricted.
Presentation transcript:

Volume 85, Issue 1, Pages 158-165 (January 2014) Worldwide, mortality risk is high soon after initiation of hemodialysis  Bruce M. Robinson, Jinyao Zhang, Hal Morgenstern, Brian D. Bradbury, Leslie J. Ng, Keith P. McCullough, Brenda W. Gillespie, Raymond Hakim, Hugh Rayner, Joan Fort, Tadao Akizawa, Francesca Tentori, Ronald L. Pisoni  Kidney International  Volume 85, Issue 1, Pages 158-165 (January 2014) DOI: 10.1038/ki.2013.252 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 Mortality after the start of dialysis. Countries were ordered by mortality rate at ≤120 days. ANZ, Australia and New Zealand; BE, Belgium; CA, Canada; DOPPS, Dialysis Outcomes and Practice Patterns Study; FR, France; GE, Germany; IT, Italy; JP, Japan; SW, Sweden; UK, United Kingdom; US, United States. Error bars correspond to 95% confidence intervals calculated using the Byar approximation. Kidney International 2014 85, 158-165DOI: (10.1038/ki.2013.252) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 2 Mortality in each DOPPS (Dialysis Outcomes and Practice Patterns Study) country versus the United States by time on hemodialysis (HD). Model adjusted for age, sex, race, and diabetes as the cause of end-stage renal disease (ESRD), stratified by study phase (N=86,886 HD patients from DOPPS census (2002–2008)). Kidney International 2014 85, 158-165DOI: (10.1038/ki.2013.252) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 3 Mortality after the start of dialysis, by age, sex, and diabetes status. (a) Association of mortality with age and vintage. †One model was fitted to each patient subgroup based on age at study enrollment (<45, 45–55, 55-64, 65–74, and ≥75 years). Ref., reference. Models were adjusted for age, sex, race, and diabetes as the cause of end-stage renal disease (ESRD), stratified by countries and study phase, and accounted for facility clustering. *Mortality rate: unadjusted number of deaths per 100 patient-years. Error bars correspond to 95% confidence intervals calculated using the Byar approximation. (b) Association of mortality with sex, diabetes status, and vintage. †One model was fitted to each patient subgroup based on sex or diabetes status at study enrollment. Models were adjusted for age, sex, race, and diabetes as the cause of ESRD, stratified by countries and study phase, and accounted for facility clustering. *Mortality rate: unadjusted number of deaths per 100 patient-years. Error bars correspond to 95% confidence intervals calculated using the Byar approximation. Kidney International 2014 85, 158-165DOI: (10.1038/ki.2013.252) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 4 Overall mortality rate by age at study enrollment. *Mortality rate: number of deaths per 100 patient-years. HD, hemodialysis. Kidney International 2014 85, 158-165DOI: (10.1038/ki.2013.252) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 5 Proportion of deaths due to withdrawal from dialysis by dialysis period and country. Countries were ordered by percent of deaths due to withdrawal from dialysis. ANZ, Australia and New Zealand; BE, Belgium; CA, Canada; FR, France; GE, Germany; IT, Italy; JP, Japan; SW, Sweden; UK, United Kingdom; US, United States. Kidney International 2014 85, 158-165DOI: (10.1038/ki.2013.252) Copyright © 2014 International Society of Nephrology Terms and Conditions